Free Trial

Robeco Schweiz AG Has $119.01 Million Holdings in Xylem Inc. (NYSE:XYL)

Xylem logo with Business Services background

Robeco Schweiz AG lessened its stake in shares of Xylem Inc. (NYSE:XYL - Free Report) by 13.0% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 996,226 shares of the industrial products company's stock after selling 148,509 shares during the quarter. Xylem comprises about 2.9% of Robeco Schweiz AG's investment portfolio, making the stock its 4th biggest holding. Robeco Schweiz AG owned 0.41% of Xylem worth $119,009,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also recently made changes to their positions in the stock. Vanguard Group Inc. boosted its holdings in shares of Xylem by 1.1% during the 4th quarter. Vanguard Group Inc. now owns 28,644,417 shares of the industrial products company's stock valued at $3,323,325,000 after acquiring an additional 303,854 shares during the last quarter. Geode Capital Management LLC boosted its holdings in shares of Xylem by 2.4% in the fourth quarter. Geode Capital Management LLC now owns 5,804,247 shares of the industrial products company's stock worth $671,623,000 after buying an additional 135,492 shares during the last quarter. Royal Bank of Canada boosted its holdings in shares of Xylem by 7.9% in the fourth quarter. Royal Bank of Canada now owns 4,369,804 shares of the industrial products company's stock worth $506,985,000 after buying an additional 320,500 shares during the last quarter. Invesco Ltd. boosted its holdings in shares of Xylem by 9.8% in the fourth quarter. Invesco Ltd. now owns 4,009,907 shares of the industrial products company's stock worth $465,229,000 after buying an additional 359,276 shares during the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in Xylem by 8.7% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,750,377 shares of the industrial products company's stock worth $435,119,000 after acquiring an additional 301,070 shares during the period. Hedge funds and other institutional investors own 87.96% of the company's stock.

Analyst Ratings Changes

A number of equities research analysts have commented on the stock. Royal Bank Of Canada raised their target price on shares of Xylem from $143.00 to $147.00 and gave the stock an "outperform" rating in a research note on Wednesday, April 30th. Stifel Nicolaus raised their target price on shares of Xylem from $140.00 to $141.00 and gave the stock a "buy" rating in a research note on Wednesday, April 30th. Robert W. Baird reduced their price objective on shares of Xylem from $149.00 to $146.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 30th. Citigroup reduced their price objective on shares of Xylem from $152.00 to $134.00 and set a "buy" rating on the stock in a research report on Monday, April 14th. Finally, JPMorgan Chase & Co. assumed coverage on shares of Xylem in a research report on Friday, May 30th. They set an "overweight" rating and a $148.00 price objective on the stock. Three analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $143.71.

View Our Latest Analysis on Xylem

Xylem Price Performance

XYL traded down $0.64 during trading hours on Friday, hitting $130.96. The company's stock had a trading volume of 1,078,928 shares, compared to its average volume of 1,418,532. The business's 50-day moving average price is $127.00 and its 200-day moving average price is $122.55. Xylem Inc. has a 12 month low of $100.47 and a 12 month high of $143.50. The stock has a market cap of $31.87 billion, a price-to-earnings ratio of 35.20, a P/E/G ratio of 2.40 and a beta of 1.12. The company has a current ratio of 1.89, a quick ratio of 1.41 and a debt-to-equity ratio of 0.18.

Xylem (NYSE:XYL - Get Free Report) last announced its quarterly earnings results on Tuesday, April 29th. The industrial products company reported $1.03 earnings per share for the quarter, topping the consensus estimate of $0.95 by $0.08. The company had revenue of $2.07 billion for the quarter, compared to analysts' expectations of $2.04 billion. Xylem had a net margin of 10.54% and a return on equity of 10.12%. Xylem's quarterly revenue was up 1.8% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.90 earnings per share. Sell-side analysts expect that Xylem Inc. will post 4.65 earnings per share for the current fiscal year.

Xylem Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, June 26th. Shareholders of record on Thursday, May 29th were paid a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 1.22%. The ex-dividend date was Thursday, May 29th. Xylem's payout ratio is 43.01%.

Xylem Company Profile

(Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

See Also

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Should You Invest $1,000 in Xylem Right Now?

Before you consider Xylem, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.

While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Hot Growth Stocks to Watch Right Now!
Don’t Miss These Top 3 Defense Stocks Set To Gain
Triple-Digit Gains: These 4 Nuclear Stocks Have Even More Upside Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines